Study to Investigate Safety and Tolerability of mRNA-0184 Administered Under Different Infusion Conditions in Healthy Participants
Clinical trial NCT06243770 · COMPLETED
Trial details
- NCT number
- NCT06243770
- Sponsor
- ModernaTX, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-16
- Primary completion
- 2025-06-12
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.